Skip to main content

azithromycin dihydrate (Azyter®)

 

Following non-submission

AWMSG advice

Status: Not endorsed (Statement of Advice)

In the absence of a submission from the holder of the marketing authorisation, azithromycin dihydrate (Azyter®) cannot be endorsed for use within NHS Wales for local antibacterial treatment of conjunctivitis caused by susceptible strains: purulent bacterial conjunctivitis and trachomatous conjunctivitis caused by Chlamydia trachomatis. Please refer to the AWMSG position statement on the appraisal of antimicrobial medicines.

 Statement of Advice (SOA): azithromycin dihydrate (Azyter) 1176 (PDF, 43Kb)

Medicine details

Medicine name azithromycin dihydrate (Azyter®)
Formulation 15 mg/g eye drops
Reference number 1176
Indication

For local antibacterial treatment of conjunctivitis caused by susceptible strains: purulent bacterial conjunctivitis and trachomatous conjunctivitis caused by Chlamydia trachomatis.

Company Spectrum Thea Pharmaceuticals
BNF chapter Eye
Assessment type Non-submission
Status Not endorsed (Statement of Advice)
Date of issue 02/11/2011
Further information

AWMSG position statement on the appraisal of antimicrobial medicines

Follow AWTTC: